Literature DB >> 18776085

Development and use of a multiplex real-time quantitative polymerase chain reaction assay for detection and differentiation of Porcine circovirus-2 genotypes 2a and 2b in an epidemiological survey.

Carl A Gagnon1, Jérome R E del Castillo, Nedzad Music, Guy Fontaine, Josée Harel, Donald Tremblay.   

Abstract

By the end of 2004, the Canadian swine population had experienced a severe increase in the incidence of Porcine circovirus-associated disease (PCVAD), a problem that was associated with the emergence of a new Porcine circovirus-2 genotype (PCV-2b), previously unrecovered in North America. Thus, it became important to develop a diagnostic tool that could differentiate between the old and new circulating genotypes (PCV-2a and PCV-2b, respectively). Consequently, a multiplex real-time quantitative polymerase chain reaction (mrtqPCR) assay that could sensitively and specifically identify and differentiate PCV-2 genotypes was developed. A retrospective epidemiologic survey that used the mrtqPCR assay was performed to determine if cofactors could affect the risk of PCVAD. From 121 PCV-2-positive cases gathered for this study, 4.13%, 92.56%, and 3.31% were positive for PCV-2a, PCV-2b, and both genotypes, respectively. In a data analysis using univariate logistic regressions, the PCVAD-compatible (PCVAD/c) score was significantly associated with the presence of Porcine reproductive and respiratory syndrome virus (PRRSV), PRRSV viral load, PCV-2 viral load, and PCV-2 immunohistochemistry (IHC) results. Polytomous logistic regression analysis revealed that PCVAD/c score was affected by PCV-2 viral load (P = 0.0161) and IHC (P = 0.0128), but not by the PRRSV variables (P > 0.9), which suggests that mrtqPCR in tissue is a reliable alternative to IHC. Logistic regression analyses revealed that PCV-2 increased the odds ratio of isolating 2 major swine pathogens of the respiratory tract, Actinobacillus pleuropneumoniae and Streptococcus suis serotypes 1/2, 1, 2, 3, 4, and 7, which are serotypes commonly associated with clinical diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18776085     DOI: 10.1177/104063870802000503

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  34 in total

1.  Effect of the modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine on European and North American PRRSV shedding in semen from infected boars.

Authors:  Kiwon Han; Hwi Won Seo; Jeoung Hwa Shin; Yeonsu Oh; Ikjae Kang; Changhoon Park; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex under Korean field conditions.

Authors:  Changhoon Park; Hwi Won Seo; Kiwon Han; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

3.  Unusual central nervous system lesions in slaughter-weight pigs with porcine circovirus type 2 systemic infection.

Authors:  Richard Drolet; François Cardinal; Alain Houde; Carl A Gagnon
Journal:  Can Vet J       Date:  2011-04       Impact factor: 1.008

4.  Alopecia areata and humpy-back syndrome in suckling piglets.

Authors:  Richard Drolet; Martine Denicourt; Sylvie D'Allaire
Journal:  Can Vet J       Date:  2012-08       Impact factor: 1.008

5.  Effects of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars.

Authors:  Hwi Won Seo; Kiwon Han; Duyeol Kim; Yeonsu Oh; Ikjae Kang; Changhoon Park; Hyun Jang; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

6.  Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts.

Authors:  Taehwan Oh; Hanjin Kim; Kee Hwan Park; Jiwoon Jeong; Ikjae Kang; Siyeon Yang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2019-10       Impact factor: 1.310

7.  Development of porcine circovirus 2 (PCV2) open reading frame 2 DNA vaccine with different adjuvants and comparison with commercial PCV2 subunit vaccine in an experimental challenge.

Authors:  Changhoon Park; Jiwoon Jeong; Kyuhyung Choi; Su-Jin Park; Ikjae Kang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

8.  Evaluation of the efficacy of a novel porcine circovirus type 2 synthetic peptide vaccine.

Authors:  Jiwoon Jeong; Changhoon Park; Seeun Kim; Su-Jin Park; Ikjae Kang; Kee Hwan Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

9.  Efficacy of Fostera PRRS modified live virus vaccine against a Canadian heterologous virulent field strain of porcine reproductive and respiratory syndrome virus.

Authors:  Christian Savard; Fernando Alvarez; Chantale Provost; Younes Chorfi; Sylvie D'Allaire; Marie-Odile Benoit-Biancamano; Carl A Gagnon
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

10.  Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV.

Authors:  Changhoon Park; Ikjae Kang; Hwi Won Seo; Jiwoon Jeong; Kyuhyung Choi; Chanhee Chae
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.